BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17235004)

  • 1. Bowel hot spots at PET-CT.
    Prabhakar HB; Sahani DV; Fischman AJ; Mueller PR; Blake MA
    Radiographics; 2007; 27(1):145-59. PubMed ID: 17235004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
    Shammas A; Lim R; Charron M
    Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved detection and characterization of adrenal disease with PET-CT.
    Elaini AB; Shetty SK; Chapman VM; Sahani DV; Boland GW; Sweeney AT; Maher MM; Slattery JT; Mueller PR; Blake MA
    Radiographics; 2007; 27(3):755-67. PubMed ID: 17495290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET CT for tumor imaging.
    Miller JC; Fischman AJ; Aquino SL; Blake MA; Thrall JH; Lee SI
    J Am Coll Radiol; 2007 Apr; 4(4):256-9. PubMed ID: 17412280
    [No Abstract]   [Full Text] [Related]  

  • 6. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
    Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
    J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma.
    Chu MM; Kositwattanarerk A; Lee DJ; Makkar JS; Genden EM; Kao J; Packer SH; Som PM; Kostakoglu L
    Radiographics; 2010 Sep; 30(5):1353-72. PubMed ID: 20833855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
    Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D
    J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
    Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
    J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment setting.
    King KG; Kositwattanarerk A; Genden E; Kao J; Som PM; Kostakoglu L
    Radiographics; 2011; 31(2):355-73. PubMed ID: 21415184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
    Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
    Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pivotal role of FDG-PET/CT in modern medicine.
    Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
    Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT evaluation of cervical cancer: spectrum of disease.
    Son H; Kositwattanarerk A; Hayes MP; Chuang L; Rahaman J; Heiba S; Machac J; Zakashansky K; Kostakoglu L
    Radiographics; 2010 Sep; 30(5):1251-68. PubMed ID: 20833849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined CT colonography and 18F-FDG PET of colon polyps: potential technique for selective detection of cancer and precancerous lesions.
    Gollub MJ; Akhurst T; Markowitz AJ; Weiser MR; Guillem JG; Smith LM; Larson SM; Margulis AR
    AJR Am J Roentgenol; 2007 Jan; 188(1):130-8. PubMed ID: 17179355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.